Five Year Patient Outcomes of Endovascular Abdominal Aortic Aneurysm Repair in the ENDURANT France Registry
| Autor: | Antoine Sauguet, Serge Haupert, Arnaud Dubar, Jean-Pierre Becquemin, Yann Jousset, Yvan Martelloni, Farah Issam |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
Reoperation medicine.medical_specialty Endoleak medicine.medical_treatment Kaplan-Meier Estimate 030204 cardiovascular system & hematology 030230 surgery law.invention Aneurysm rupture 03 medical and health sciences 0302 clinical medicine Aneurysm Randomized controlled trial law medicine Humans Registries Aged business.industry Endovascular Procedures Stent Middle Aged medicine.disease Secondary procedure Conversion to Open Surgery Survival Analysis Abdominal aortic aneurysm Surgery Treatment Outcome Private practice Sac shrinkage Female France Cardiology and Cardiovascular Medicine business Aortic Aneurysm Abdominal |
| Zdroj: | European Journal of Vascular and Endovascular Surgery. 61:98-105 |
| ISSN: | 1078-5884 |
| DOI: | 10.1016/j.ejvs.2020.08.034 |
| Popis: | Objective Endovascular repair is the preferred method of treatment for infrarenal abdominal aortic aneurysms with numerous publications from multiple geographic regions showing excellent patient outcomes. Since the original ACE (Anevrysme de l'aorte abdominale: Chirurgie versus Endoprothese) randomised control trial, studies of French specific population have also contributed significantly to the body of evidence in support of endovascular abdominal aortic repair. Methods In the ENDURANT France registry, 180 patients were consecutively enrolled from 20 French centres starting in 2012. Investigational sites included public and private practice and differing centre volumes to be as representative of real world French experience as possible. The aim of this study was to present the five year outcomes from this registry. Results Instructions for use (IFU) were respected in 97.8% (176/180) of patients. At five years, the Kaplan–Meier overall survival was 69.9% ± 3.5% and the freedom from aneurysm related death was 97.6% ± 1.2%. The freedom from Type IA endoleaks was 94.5% ± 1.7%, freedom from endoleaks of any type was 70.1 ± 3.4%, and freedom from secondary endovascular procedure 90.4% ± 2.6%. In addition, 61.6% (45/73) of patients exhibited sac shrinkage at five years. Conclusion In this five year report of the Endurant France registry, survival, re-intervention, and freedom from endoleak rates were comparable to recent EVAR registries and there was a high sac shrinkage rate. Secondary procedure and aneurysm rupture were lower than those of ACE, the French RCT which included older generation devices. This prospective registry demonstrates favourable five year outcomes of the Endurant stent graft used within IFU. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect